Patna Medicity Hospital And Research Institute Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-12-2024
- Paid Up Capital ₹ 5.00 M
as on 03-12-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 16.03%
(FY 2022)
- Profit 166.45%
(FY 2022)
- Ebitda 2899.07%
(FY 2022)
- Net Worth 39.51%
(FY 2022)
- Total Assets 30.91%
(FY 2022)
About Patna Medicity Hospital And Research Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arun Kumar, Gautam, and Nasibulain Ansari serve as directors at the Company.
- CIN/LLPIN
U93000BR2016PTC032042
- Company No.
032042
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Patna Medicity Hospital And Research Institute?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kumar  | Director | 30-Sep-2023 | Current |
| Gautam | Director | 15-Jul-2016 | Current |
| Nasibulain Ansari | Additional Director | 01-Mar-2024 | Current |
Financial Performance of Patna Medicity Hospital And Research Institute.
Patna Medicity Hospital And Research Institute Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.03% increase. The company also saw a substantial improvement in profitability, with a 166.45% increase in profit. The company's net worth Soared by an impressive increase of 39.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Patna Medicity Hospital And Research Institute?
In 2022, Patna Medicity Hospital And Research Institute had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Patna Medicity Hospital And Research Institute?
Patna Medicity Hospital And Research Institute has a workforce of 0 employees as of Oct 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Patna Medicity Hospital And Research Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Patna Medicity Hospital And Research Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
